Gernot Stuhler

5.0k total citations · 2 hit papers
53 papers, 3.0k citations indexed

About

Gernot Stuhler is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Gernot Stuhler has authored 53 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 24 papers in Hematology and 14 papers in Oncology. Recurrent topics in Gernot Stuhler's work include Hematopoietic Stem Cell Transplantation (23 papers), Immunotherapy and Immune Responses (20 papers) and Immune Cell Function and Interaction (17 papers). Gernot Stuhler is often cited by papers focused on Hematopoietic Stem Cell Transplantation (23 papers), Immunotherapy and Immune Responses (20 papers) and Immune Cell Function and Interaction (17 papers). Gernot Stuhler collaborates with scholars based in Germany, France and Israel. Gernot Stuhler's co-authors include Peter Brossart, Lothar Kanz, Volker L. Reichardt, Wolfram Brugger, Stefan Wirths, Stefan Stevanović, Anke Zobywalski, Shairaz Baksh, Erwin Bohn and Klaus Schulze‐Osthoff and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Gernot Stuhler

53 papers receiving 2.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signal

2003 756 citations Kirsten Lauber, Erwin Bohn et al. Cell profile →
Bispecific and multispecific antibodies in oncology: opportunities and challenges

2024 65 citations Gernot Stuhler, Ralf C. Bargou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gernot Stuhler Germany	25	2.1k	1.1k	819	589	304	53	3.0k
Frank Grünebach Germany	38	2.4k 1.2×	1.8k 1.6×	1.3k 1.5×	646 1.1×	193 0.6×	73	4.2k
Wasif N. Khan United States	32	2.6k 1.2×	1.0k 0.9×	540 0.7×	362 0.6×	321 1.1×	69	3.9k
Niels Bovenschen Netherlands	29	1.1k 0.5×	945 0.8×	531 0.6×	590 1.0×	166 0.5×	83	2.7k
Mitsuru Tsudo Japan	27	2.1k 1.0×	532 0.5×	862 1.1×	287 0.5×	305 1.0×	75	3.1k
Giuseppe Sconocchia Italy	32	1.2k 0.6×	698 0.6×	1.1k 1.3×	529 0.9×	106 0.3×	88	2.6k
Anne B. Satterthwaite United States	31	2.5k 1.2×	1.1k 1.0×	445 0.5×	402 0.7×	325 1.1×	57	3.7k
Nobuhiro Tsukada Japan	20	1.2k 0.6×	750 0.7×	658 0.8×	886 1.5×	133 0.4×	140	2.9k
Roberta Pelanda United States	35	3.2k 1.6×	1.5k 1.3×	774 0.9×	266 0.5×	611 2.0×	84	4.9k
Evan Lind United States	20	2.0k 1.0×	970 0.9×	584 0.7×	388 0.7×	91 0.3×	36	3.2k
Gary C. Starling United States	28	1.6k 0.8×	894 0.8×	658 0.8×	417 0.7×	198 0.7×	59	2.6k

Countries citing papers authored by Gernot Stuhler

Since Specialization

Citations

This map shows the geographic impact of Gernot Stuhler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gernot Stuhler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gernot Stuhler more than expected).

Fields of papers citing papers by Gernot Stuhler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gernot Stuhler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gernot Stuhler. The network helps show where Gernot Stuhler may publish in the future.

Co-authorship network of co-authors of Gernot Stuhler

This figure shows the co-authorship network connecting the top 25 collaborators of Gernot Stuhler. A scholar is included among the top collaborators of Gernot Stuhler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gernot Stuhler. Gernot Stuhler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baron, Frédéric, Myriam Labopin, Annalisa Ruggeri, et al.. (2019). Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT. Blood Cancer Journal. 9(4). 15 indexed citations

Czyż, Anna, Myriam Labopin, Sebastian Giebel, et al.. (2018). Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph‐negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow Transplantation. American Journal of Hematology. 93(6). 778–785. 11 indexed citations

Hałaburda, Kazimierz, Myriam Labopin, Mohamed Houhou, et al.. (2018). AlloHSCT for inv(3)(q21;q26)/t(3;3)(q21;q26) AML: a report from the acute leukemia working party of the European society for blood and marrow transplantation. Bone Marrow Transplantation. 53(6). 683–691. 13 indexed citations

Rasche, Leo, Christoph Röllig, Gernot Stuhler, et al.. (2016). Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features. Biology of Blood and Marrow Transplantation. 22(11). 1988–1996. 35 indexed citations

Kneitz, Susanne, et al.. (2016). Silencing of CDK2, but not CDK1, separates mitogenic from anti-apoptotic signaling, sensitizing p53 defective cells for synthetic lethality. Cell Cycle. 15(23). 3203–3209. 8 indexed citations

Kapp, Markus, Stephan Mielke, Jürgen Loeffler, et al.. (2015). Control of relapsed or refractory acute myeloid leukemia by clofarabine in preparation for allogeneic stem cell transplant. Leukemia & lymphoma. 56(12). 3365–3369. 1 indexed citations

Mezger, Markus, Martin Bornhäuser, Rudolf Trenschel, et al.. (2014). KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts. Annals of Hematology. 93(9). 1579–1586. 28 indexed citations

Kneitz, Susanne, et al.. (2014). Silencing of Dicer1 temporally separates pro- and anti-apoptotic signaling and confers susceptibility to chemotherapy in p53 mutated cells. Cell Cycle. 13(14). 2192–2198. 3 indexed citations

Federmann, Birgit, Martin Bornhäuser, Christoph Meisner, et al.. (2012). Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study. Haematologica. 97(10). 1523–1531. 86 indexed citations

10.

Patriarca, Francesca, Hermann Einsele, Francesco Spina, et al.. (2011). Allogeneic Stem Cell Transplantation in Multiple Myeloma Relapsed after Autograft: A Multicenter Retrospective Study Based on Donor Availability. Biology of Blood and Marrow Transplantation. 18(4). 617–626. 54 indexed citations

11.

Kapp, Markus, Marc Schargus, Jan Springer, et al.. (2011). Endophthalmitis as primary clinical manifestation of fatal fusariosis in an allogeneic stem cell recipient. Transplant Infectious Disease. 13(4). 374–379. 13 indexed citations

12.

Schoen, Christoph, Christian Unzicker, Gernot Stuhler, et al.. (2009). Life-Threatening Infection Caused by Daptomycin-Resistant Corynebacterium jeikeium in a Neutropenic Patient. Journal of Clinical Microbiology. 47(7). 2328–2331. 25 indexed citations

13.

Kapp, Markus, Stefan Stevanović, Sen Mui Tan, et al.. (2009). CD8+ T-cell responses to tumor-associated antigens correlate with superior relapse-free survival after allo-SCT. Bone Marrow Transplantation. 43(5). 399–410. 42 indexed citations

14.

Federmann, Birgit, Martin Bornhäuser, Dietrich W. Beelen, et al.. (2008). Haploidentical Allogeneic Hematopoietic Cell Transplantation in Adults Using Reduced Intensity Conditioning and CD3/CD19-Depleted Grafts: Interim Analysis of a Phase I/II Study.. Blood. 112(11). 1962–1962. 2 indexed citations

15.

Bethge, Wolfgang, Christoph Faul, Martin Bornhäuser, et al.. (2007). Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: An update. Blood Cells Molecules and Diseases. 40(1). 13–19. 103 indexed citations

16.

Lauber, Kirsten, Erwin Bohn, Stefan Kröber, et al.. (2003). Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signal. Cell. 113(6). 717–730. 756 indexed citations breakdown →

17.

Stuhler, Gernot & Peter Walden. (2002). Cancer immune therapy : current and future strategies. Wiley-VCH eBooks. 3 indexed citations

18.

Pettengell, Ruth, et al.. (2000). Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1500(3). 265–279. 76 indexed citations

19.

Brossart, Peter, Gernot Stuhler, Thomas Flad, et al.. (1998). Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.. PubMed. 58(4). 732–6. 192 indexed citations

20.

Stuhler, Gernot & Peter Walden. (1994). Recruitment of helper T cells for induction of tumour rejection by cytolytic T lymphocytes. Cancer Immunology Immunotherapy. 39(5). 342–345. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact